FDA Drug Approval, N018893, SODIUM ACETATE
FDA Drug Approval, N018893, SODIUM ACETATE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 018893
Company: HOSPIRA
Drug Name: SODIUM ACETATE
Active Ingredients: SODIUM ACETATE
Strength: 200MEQ/100ML (2MEQ/ML)
Dosage Form/Route: SOLUTION;INTRAVENOUS
Action Date: 05/04/1983
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: HOSPIRA
Drug Name: SODIUM ACETATE
Active Ingredients: SODIUM ACETATE
Strength: 200MEQ/100ML (2MEQ/ML)
Dosage Form/Route: SOLUTION;INTRAVENOUS
Action Date: 05/04/1983
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details